Heron Therapeutics | HRTX - Trade Creditors


Heron Therapeutics reported $11.64M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
ALKERMES USD 142.86M 40.5M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
ANI Pharmaceuticals USD 73.83M 4.14M Jun/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
Eisai JPY 87.53B 11.64B Jun/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Insmed USD 74.55M 1.18M Jun/2026
Ligand Pharmaceuticals USD 9.4M 27.7M Jun/2026
Merck USD 3.83B 36M Jun/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 17.51M 3.5M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Veracyte USD 8.02M 1.12M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026